HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

LVMH sales

This article was originally published in The Rose Sheet

Executive Summary

Fragrance and cosmetics sales jumped more than 22% to approximately $856.6 mil. in the first half, the company announces July 11. Givenchy's Oblique Play, Fast Forward and Rewind has had "great success" in Europe; the women's scent is coming to the U.S. in September. Givenchy's Indecence, Kenzo's Time for Peace and Christian Dior's j'adore continued to perform well, as well as the recently acquired niche beauty businesses, which include Bliss, BeneFit, Hard Candy and Urban Decay, LVMH says. In the U.S., LVMH's beauty business sales increased over 40%. Consolidated sales grew more than 40% to roughly $4.78 bil

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008217

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel